Rockwell Medical, Inc. (RMTI)

Rockwell Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	86.62	83.61	72.81	61.93	62.2	61.3
Revenue Growth (YoY)	13.45%	14.84%	17.57%	-0.43%	1.46%	-3.29%
Cost of Revenue	77.45	74.91	68.73	64.35	59.47	58.46
Gross Profit	9.17	8.7	4.08	-2.42	2.73	2.84
Selling, General & Admin	14.89	14.27	17.74	21.08	24.05	30.05
Research & Development	0.85	1.11	3.12	6.84	7.09	6.89
Other Operating Expenses	0	0	0	0	0	0.43
Operating Expenses	15.74	15.37	20.86	27.92	31.15	37.36
Operating Income	-6.57	-6.67	-16.78	-30.34	-28.42	-34.53
Interest Expense / Income	2.35	2.3	1.94	2.36	1.88	0.03
Other Expense / Income	-0.49	-0.53	-0.04	-0.02	0.59	-0.42
Pretax Income	-8.42	-8.44	-18.68	-32.67	-30.89	-34.13
Net Income	-8.42	-8.44	-18.68	-32.67	-30.89	-34.13
Shares Outstanding (Basic)	29	23	14	9	7	6
Shares Outstanding (Diluted)	29	23	14	9	7	6
Shares Change	59.73%	63.05%	67.77%	24.02%	24.14%	15.32%
EPS (Basic)	-0.36	-0.37	-1.31	-3.83	-4.51	-6.16
EPS (Diluted)	-0.36	-0.37	-1.31	-3.83	-4.51	-6.16
Free Cash Flow	-8.19	-9.7	-17.21	-34.06	-30.69	-27.84
Free Cash Flow Per Share	-0.28	-0.42	-1.20	-3.99	-4.46	-5.03
Gross Margin	10.59%	10.41%	5.60%	-3.91%	4.38%	4.63%
Operating Margin	-7.58%	-7.98%	-23.05%	-48.98%	-45.69%	-56.32%
Profit Margin	-9.72%	-10.09%	-25.65%	-52.76%	-49.66%	-55.67%
Free Cash Flow Margin	-9.46%	-11.60%	-23.64%	-54.99%	-49.34%	-45.42%
EBITDA	-2.2	-2.68	-14.15	-27.8	-26.72	-31.45
EBITDA Margin	-2.54%	-3.21%	-19.44%	-44.89%	-42.96%	-51.30%
Depreciation & Amortization	3.87	3.45	2.59	2.52	2.29	2.65
EBIT	-6.08	-6.14	-16.74	-30.31	-29.01	-34.1
EBIT Margin	-7.01%	-7.34%	-23.00%	-48.95%	-46.64%	-55.63%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).